Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYR-619 in Type 2 Diabetes
NCT00763347Phase 2Terminated
- Sponsor
- Takeda
- Start
- Nov 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of SYR-619 in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Nov 2006; status: terminated.
02
Drugs
SYR-619
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00763347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763347.